Volume 65, Issue 6, Pages 2321-2334 (June 2004) The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study  Michael V. Rocco, Johanna T. Dwyer, Brett Larive, Tom Greene, David B. Cockram, W. Cameron Chumlea, John W. Kusek, June Leung, Jerrilynn D. Burrowes, Sandy L. McLeroy, Diane Poole, Leigh Uhlin, for the HEMO Study Group  Kidney International  Volume 65, Issue 6, Pages 2321-2334 (June 2004) DOI: 10.1111/j.1523-1755.2004.00647.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 The change in serum albumin levels by the nephelometry method is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 The change in postdialysis weight is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 The change in equilibrated protein catabolic rate is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 The change in adjusted protein intake is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 The change in adjusted energy intake is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 The change in calf circumference is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 The change in upper arm circumference is shown for the dose intervention (A) and the flux intervention (B). In each panel, the adjusted values for the low or standard group are denoted (•) and the adjusted values for the high group are denoted (○). Diamonds indicate unadjusted mean changes for those patients surviving to their respective follow-up time points in the low or standard group (♦) and high group (⋄). Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 8 The estimated mean change in serum albumin levels using raw mean data and using three different informative censoring models. Data areshown for the standard dose group. An explanation of the three different models is provided in the Appendix. Kidney International 2004 65, 2321-2334DOI: (10.1111/j.1523-1755.2004.00647.x) Copyright © 2004 International Society of Nephrology Terms and Conditions